|
⚲
|
| Keyboard |
| PGIM Wadhwani LLP
✚
|
|
|---|---|
| CRD # | 161434 |
| SEC # | 801-96244 |
| CIK # | 0001723357, 0001348144 |
| AUM | |
| Employees | 49 (51% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 4402076633400 |
| Address | 9th Floor Orion House London, United Kingdom |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/27/2024) [Brochure] |
|---|
Item 5 Fees and Compensation
We are compensated for our advisory services under both asset-based and performance-based fee
schedules. Our asset-based management fees are negotiable and vary based on factors such as the
investment strategy and associated volatility level. Fees are charged monthly based on a percentage of
net assets, are payable monthly or quarterly in arrears and, pursuant to direction from the Client, are
deducted directly from the Client’s assets as such fees become payable. PGIM Wadhwani’s fees for
advisory services are set out in the applicable offering memorandum for the Funds, and in the investment
management agreement for the Managed Accounts. See Item 6 below for more information about
performance fees and the potential conflicts of interest they create.
As set out in the relevant offering memorandum, the Funds are responsible for all costs and expenses
incurred in connection with the investments in each Fund, including brokerage commissions and exchange,
clearing and regulatory fees. They are also responsible for each Fund’s operating expenses, which
typically include: the fees and expenses of a fund administrator, custodians, banks, directors, auditors,
legal and tax advisors, and risk analytics providers; withholding, transfer or similar taxes; insurance costs;
any applicable registration, license, membership or similar fees payable to any government, exchange, or
regulatory or self-regulatory organization; and the costs of maintaining the registered office of each Fund.
Without prejudice to the above, PGIM Wadhwani could, from time to time and at its sole discretion, as
outlined in the applicable Fund prospectus or investment management agreement, and out of its own
resources, decide to rebate to some or all investors or to their agents or intermediaries part or all of the
fees it receives in relation to the Funds.
Please refer to the relevant Fund’s offering memorandum for a complete understanding of each Fund’s
fees and expenses. The information contained herein is a summary only and is qualified in its entirety by
the relevant Fund’s offering memorandum.
Expenses charged on a Managed Account are negotiated separately at the time of such account’s opening.
Neither PGIM Wadhwani nor its supervised persons accept any compensation from third parties for the
sale (or purchase) of investment products. PGIM Wadhwani receives all of its compensation from clients
in the form of investment management fees.
PGIM Wadhwani does not require or solicit prepayment of fees from its clients.
Page5 |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/27/2024) [Brochure] |
|---|
Item 7 Types of Clients
As described in Item 4 above, our Clients are the Funds and Managed Accounts.
Our Clients currently include a registered investment company and its investment manager, non-U.S. funds
such as Undertakings for Collective Investment in Transferable Securities (“UCITS”) and alternative
investment funds, and three single managed accounts.
We provide our services to both affiliated and non-affiliated Clients.
Page9 |
| CIK | Period |
|---|---|
| 0001723357 0001348144 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Apple Inc | 3.7 | ||
| Microsoft Corp | 3.3 | ||
| Nvidia Corp | 3.2 | ||
| Amazon Com Inc | 1.9 | ||
| Facebook Inc | 1.3 | ||
| Alphabet Inc | 1.1 | ||
| Alphabet Inc | 0.9 | ||
| Lilly Eli & Co | 0.8 | ||
| Broadcom Inc | 0.8 | ||
| Tesla Motors Inc | 0.7 | ||
| J P Morgan Chase & Co | 0.7 | ||
| UnitedHealth Group Inc | 0.5 | ||
| AMB Property Corp | 0.5 | ||
| Johnson & Johnson | 0.5 | ||
| Mastercard Inc | 0.5 | ||
| Netflix Inc | 0.4 | ||
| Visa Inc | 0.4 | ||
| Home Depot Inc | 0.4 | ||
| AbbVie Inc | 0.4 | ||
| Merck & Co Inc | 0.4 | ||
| Health Care REIT Inc /DE/ | 0.4 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | PGIM Wadhwani Macro Tail Risk Master Fund Limited | [2023-03-30] | 25.0 M | 36.5 M |
| Filed 2023-08-10 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Commodity & Macro Tail Risk Master Fund Limited | [2022-03-30] | 22.5 M | 60.1 M |
| Filed 2024-02-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | The Keynes Dynamic Beta Strategy Offshore Master Fund Limited | [2019-01-17] | 3.0 M | 281.3 M |
| Filed 2024-06-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | The Keynes Multi Risk Premia Master Fund Limited | 2018-04-12 | ||
| HF | The Keynes Multi Asset Value Master Fund Limited | [2016-03-30] | 142.2 M | 465.6 M |
| Filed 2024-06-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | The Keynes Leveraged Quantitative Strategies Master Fund Limited | [2012-03-30] | 142.2 M | 733.1 M |
| Filed 2024-06-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | The Keynes Quantitative Strategies Master Fund Limited | 2012-03-30 | 4.7 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 39.4 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 1,400.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 1 | 32.1 |
| (i) State or municipal government entities | 1 | 102.4 |
| (j) Other investment advisers | 1 | 20.8 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 1,595.7 |
| By Discretionary | ||
| Discretionary | 9 | 1,595.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 1,595.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 1,400.9 | |
| United States Persons | 194.8 | |
| Total | 9 | 1,595.7 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Linburgh Martin | Director | 208 | 26 | |
| James Baker | Director | 30 | 4 | |
| Scott Bernstein | Director | 14 | 3 | |
| Peter Astleford | Director | 6 | 3 | |
| Mark Shadwick | Director | 6 | 3 | |
| Limburgh Martin | Director | 5 | 2 | |
| Pgim Wadhwani Llp | Promoter | 2 | 1 | |
| Baker James | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001723357] | |
| 13F-NT | [0001723357] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300V7WW5QGUQI1C74 |